Clinical observation of Anlotinib combined with Pemetrexed and Nedaplatin in treating EGFR/ALK/ROS1 muta-tion-negative advanced lung adenocarcinoma

ZHANG Li-ping; ZHANG Qi-zhou; JIN Jun; LIU Xi-juan; ZHAO Yuan-yuan; YU Xi-he; LIN Hui; MA Li-ping

doi:10.13820/j.cnki.gdyx.20200278

Home>Articles>Clinical observation of Anlotinib combined with Pemetrexed and Nedaplatin in treating EGFR/ALK/ROS1 muta-tion-negative advanced lung adenocarcinoma

DOI: 10.13820/j.cnki.gdyx.20200278

Clinical observation of Anlotinib combined with Pemetrexed and Nedaplatin in treating EGFR/ALK/ROS1 muta-tion-negative advanced lung adenocarcinoma

ZHANG Li-ping

ZHANG Qi-zhou

JIN Jun

LIU Xi-juan

ZHAO Yuan-yuan

YU Xi-he

LIN Hui

MA Li-ping

Machine-generated Keywords：

Publication Date：2021-01-25

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：6( 151-156 )

Guangdong Medical Journal

PKUISTIC

ISSN：1001-9448

Year, Vol.(Issue)：2021,42(2)